Gandal Science (New York, N.Y.) 2019 (Pubmed ID 30545856)

syn22352312

Created By Kelsey Montgomery kelsey

DOI: 10.1126/science.aat8127
year: 2019
study: UCLA-ASD Capstone Collection BrainGVEX
title: Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder.
grants: R01MH094714 U01MH103340 P50MH106934 UO1MH103339 U01MH103346 R21MH103877 U01MH103392 U01MH103392 U01MH103365 R01MH094714 U01MH103339 U01MH103340 R01MH110920
authors: Gandal MJ, Zhang P, Hadjimichael E, Walker RL, Chen C, Liu S, Won H, van Bakel H, Varghese M, Wang Y, Shieh AW, Haney J, Parhami S, Belmont J, Kim M, Moran Losada P, Khan Z, Mleczko J, Xia Y, Dai R, Wang D, Yang YT, Xu M, Fish K, Hof PR, Warrell J, Fitzgerald D, White K, Jaffe AE, Peters MA, Gerstein M, Liu C, Iakoucheva LM, Pinto D, Geschwind DH
journal: Science (New York N.Y.)
abstract: Most genetic risk for psychiatric disease lies in regulatory regions, implicating pathogenic dysregulation of gene expression and splicing. However, comprehensive assessments of transcriptomic organization in diseased brains are limited. In this work, we integrated genotypes and RNA sequencing in brain samples from 1695 individuals with autism spectrum disorder (ASD), schizophrenia, and bipolar disorder, as well as controls. More than 25% of the transcriptome exhibits differential splicing or ex
pubmedId: 30545856
entity_name: Gandal Science (New York, N.Y.) 2019 (Pubmed ID 30545856)

Gandal Science (New York, N.Y.) 2019 (Pubmed ID 30545856) page is loading…